Related Experiment Video
Updated: Aug 18, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Inter- and intra-patient sequence diversity among parainfluenza virus-type 1 nucleoprotein genes
V P Dave1, S V Hetherington, A Portner
1Department of Immunology, St. Jude Children's Research Hospital, Tennessee, USA.
Abstract:
Parainfluenza viruses (PIV) have been categorized into four discrete types (types 1-4), based on antigenic similarities. Here is described an evaluation of nucleoprotein (NP) sequence variability among nine patients infected with the type 1 virus. The examination of short segments of the NP sequence was sufficient to define significant variability both within and between patient samples. These data, in conjunction with previous studies of hemagglutinin-neuraminidase and fusion protein sequences from PIV-infected patient populations suggest a lack of absolute stability among isolates within each virus type. Potentially, antigenic variability exists to the extent that an immune response elicited toward one isolate may not be fully protective against another of the same type. Thus, sequence variability could contribute to natural re-infections with PIV, as well as to previous vaccine failures. Results highlight the importance of analyzing viruses that break through vaccine-induced immunity, in order to measure the influence of virus diversity on PIV vaccine outcome.
Insights
Parainfluenza virus (PIV) type 1 shows significant genetic variability in its nucleoprotein (NP) sequence. This diversity may explain PIV re-infections and vaccine failures.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Parainfluenza viruses (PIV) are classified into four types (1-4) based on antigenic properties.
- Understanding PIV genetic diversity is crucial for vaccine development and efficacy.
Purpose of the Study:
- To evaluate the sequence variability of the nucleoprotein (NP) gene in human PIV type 1 isolates.
- To assess the implications of PIV genetic diversity on immune response and vaccine effectiveness.
Main Methods:
- Analysis of short nucleoprotein (NP) gene segments from nine patients infected with PIV type 1.
- Comparison of sequence variability within and between patient samples.
Main Results:
- Significant genetic variability was observed in the NP sequence of PIV type 1, both within and between patients.
- Previous studies indicated variability in hemagglutinin-neuraminidase and fusion protein sequences of PIV.
Conclusions:
- PIV isolates within the same type exhibit considerable genetic instability.
- Sequence variability may lead to immune responses not fully protective against homologous PIV types, contributing to re-infections and vaccine failures.
- Analyzing breakthrough viruses is essential to understand the impact of PIV diversity on vaccine outcomes.
More Related Videos
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Viral Recombination
Viral Mutations
Leaky Scanning
Size and Structure of Viral Genomes
Influenza